Translate this page into:
Ectopic Parathyroid Adenoma Mimicking as a Neuroendocrine Tumor on Ga68- DOTANOC Positron Emission Tomography/Computed Tomography Imaging
Address for correspondence: Dr. Rajender Kumar, Associate Professor, Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. E-mail: drrajender2010@gmail.com
-
Received: ,
Accepted: ,
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Parathyroid adenoma sometimes present in ectopic location and may pose a difficulty in both diagnosis and localization. We report a case of a young lady suspected to have neuroendocrine tumor of the mediastinum demonstrating synaptophysin positivity on an initial core needle biopsy. Ga-68 DOTANOC positron emission tomography–computed tomography revealed a somatostatin receptor-expressing lesion in the anterior mediastinum with tracer avid multiple lytic bone lesions. On further biochemical and imaging workup with Tc-99 m SESTAMIBI, a diagnosis of ectopic parathyroid adenoma was made which was further confirmed with surgical excision.
Keywords
Ectopic parathyroid adenoma
Ga-68 DOTANOC positron emission tomography/computed tomography
neuroendocrine tumor
Tc-99 m SESTAMIBI
A 43-year-old hypertensive woman presented with history of breathlessness. Initial chest X-ray examination showed mediastinal widening. Noncontrast computed tomography (CT) of the chest showed an anterior mediastinal lesion with extension to the hilar region of the right lung. A core needle biopsy was obtained, and immunohistochemistry (IHC) showed synaptophysin positivity, suggesting a grade I neuroendocrine tumor. Subsequently, a Ga-68 DOTANOC positron emission tomography/CT (PET/CT) was performed for staging the disease, which showed increased tracer uptake in the mediastinal region (Maximum Intensity Projection (MIP) image; [Figure 1a] Trans-axial contrast-enhanced CT [Figure 1b] and fused PET/CT [Figure 1c] images showed a heterogeneously enhancing mass (~5.8 cmx 5.6 cm, with few areas of necrosis) in the anterior mediastinum and extending to the right parahilar region with a SUVmax 9.6. A few tracer avid lytic lesions were also noted in the bilateral iliac bones [Figure 1d and e, SUVmax 6.2] and scapula (SUVmax 4.6).

The patient was planned for surgical excision of the mass lesion and on preoperative workup, her biochemical investigations demonstrated hypercalcemia (Serum calcium 17.6 mg/dl). Further biochemical evaluation revealed elevated serum parathormone levels (PTH – 1295 pg/ml). A Tc-99 m SESTAMIBI scan was planned to detect the presence of any parathyroid adenoma. Dual time point Tc-99 m SESTAMIBI scan ([Figure 2a]-early image at 10 min postinjection [p. i.] and [Figure 2b] – delayed image 2 h p. i.) revealed the presence of a tracer avid mass lesion (white arrow) in the mediastinum, corresponding to the site of the lesion visualized on Ga-68 DOTANOC PET/CT. She underwent surgical excision of the anterior mediastinal mass. Postoperative histopathology findings confirmed a diagnosis of an ectopic parathyroid adenoma. Her serum PTH levels 1 week after surgery significantly reduced to 82 pg/ml. Ectopic parathyroid adenomas account for about 4%–10% of the pathology in patients with hyperparathyroidism.[1] They can be present anywhere from the base of the tongue to the mediastinum.[2] USG, 4D CT, and Tc-99 m Sestamibi scan are the first line investigations used to evaluate parathyroid adenomas.[3] Tc-99 m SESTAMIBI localizes to parathyroid adenomas because of the presence of high mitochondrial content in oxyphil cells.[4] The parathyroid adenomas are known to express Somatostatin Receptors (SSTRs)[5] and may also show positivity with synaptophysin on IHC, leading to a misinterpretation as a tumor of neuroendocrine origin.[6] Ga68-DOTANOC PET/CT has previously demonstrated detection of parathyroid adenomas at their native location due to the expression of SSTRs.[7] The present case highlights that parathyroid adenomas at the ectopic location may pose a diagnostic challenge because of the resemblance with neuroendocrine tumors with such SSTR targeted imaging agents.

Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- Incidence and location of ectopic abnormal parathyroid glands. Am J Surg. 2006;191:418-23.
- [Google Scholar]
- Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes. 2012;120:604-10.
- [Google Scholar]
- Clinical images: Four-dimensional computed tomography-future of preoperative parathyroid adenoma imaging. Ochsner J. 2017;17:220-2.
- [Google Scholar]
- Somatostatin receptor expression in parathyroid neoplasms. Endocr Connect. 2019;8:1213-23.
- [Google Scholar]
- Clinicopathologic features of parathyroid carcinoma: A study of 11 cases with review of literature. Zhonghua Bing Li Xue Za Zhi. 2014;43:296-300.
- [Google Scholar]
- Incidental detection of parathyroid adenoma on somatostatin receptor PET/CT and incremental role of 18F-fluorocholine PET/CT in MEN1 syndrome. Nucl Med Mol Imaging. 2018;52:238-42.
- [Google Scholar]
